SCHEMBL757014

SCHEMBL757014

Cc1c(O[C@H]2CCN(C(=O)O)C[C@H]2F)ncnc1N1CCc2ncccc21

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 19/20 0.36
CYP2C9 P11712 1/20 0.33
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290047 1.00 GPR119 (0.36) GPR119CYP2C9PIK3CD
SCHEMBL300080 1.00 GPR119 (0.36) GPR119CYP2C9PIK3CD
SCHEMBL3512362 1.00 GPR119 (0.36) GPR119CYP2C9PIK3CD
SCHEMBL756593 0.89 GPR119 (0.44) GPR119PIK3CD
SCHEMBL756592 0.89 GPR119 (0.44) GPR119PIK3CD
SCHEMBL756660 0.89 GPR119 (0.35) GPR119CYP2C9PIK3CD
SCHEMBL756178 0.88 GPR119 (0.42) GPR119CYP2C9
SCHEMBL298534 0.88 GPR119 (0.42) GPR119CYP2C9
SCHEMBL299176 0.88 GPR119 (0.42) GPR119CYP2C9
SCHEMBL288068 0.86 GPR119 (0.47) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100285145-A1 GPR 119 MODULATORS PFIZER INC 2010-11-11 US claimed
US-20120052130-A1 GPR 119 MODULATORS PFIZER INC. 2012-03-01 US disclosed
US-20100285145-A1 GPR 119 MODULATORS PFIZER INC 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120052130-A1 GPR 119 MODULATORS GPR119, GPR39, GPR65 GPR119 1/4885CYP2C9 722/4885PIK3CD 2858/4885
US-20100285145-A1 GPR 119 MODULATORS GPR119, GPR65, GPR39 GPR119 1/4885CYP2C9 1406/4885PIK3CD 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.